EPISODE · Jul 9, 2012 · 16 MIN
Emerging HDL Therapies: What’s Next on the Clinical Research Horizon
from Lipid Luminations
Host: Alan S. Brown, MD, FACC, FAHA, FNLA Guest: Benjamin J. Ansell, MD, FACC, FACP, FNLA Host Dr. Alan Brown welcomes Benjamin Ansell, MD, professor of medicine and cardiology at University of Califronia at Los Angeles, CA and co-director of the Cholesterol and Hypertension Management Program at UCLA. Dr. Ansell reviews the latest trials: dal-OUTCOMES and AIM-HIGH. Dr. Ansell will address the objectives and study designs of both studies and explain why the studies were stopped early. Drs. Brown and Ansell also discuss the future of HDL therapy. Brought to you by:
Embed this episode
NOW PLAYING
Emerging HDL Therapies: What’s Next on the Clinical Research Horizon
No transcript for this episode yet
Similar Episodes
No similar episodes found.